Chemspec Europe postponed to 2022
Due to the ongoing COVID-19 pandemic and continued uncertainties about international travel, Mack-Brooks Exhibitions has announced the postponement of Chemspec Europe 2021, which was scheduled to take place at Messe Frankfurt on 29-30 September 2021. It will now return to its late spring slot on 31 May-1 June 2022, at the same venue.
Instead, an interactive networking event will take place on the original dates, as it did in 2020, featuring virtual stands, product showcases and matchmaking. “This is to allow sufficient planning security for all parties involved whilst benefitting from a proven virtual marketplace to conduct business,” the company said. Further details will be released shortly.
RELATED ARTICLES
Evonik is making a “mid-double-digit million euro investment” in a production facility for its Aeroxide brand of fumed aluminium oxide at its site in Yokkaichi, Japan (pictured).
CDMO Flamma Group is to invest about $200 million over the next three years across its network of sites in Italy, the US and China, as it “continues to respond to market demands that require future growth and opportunity”. This includes:
The UK speciality chemicals industry lost one of its leading lights on 17 December 2022, when Dr David Karsa passed away after suffering severe organ failure.
Following a review over the past few months of its of its manufacturing capacity relative to customer needs and market trends across its product portfolio, Veranova’s Macfarlan Smith subsidiary has announced a proposal to close its facility at Newbie, near Annan in Scotland.
Within the Restrictions Roadmap under the EU’s Chemicals Strategy for Sustainability, ECHA has released its Regulatory Strategy for Flame Retardants (FRs). This refers mainly to halogenated FRs and organophosphorus-based FRs, which make up about 70% of the organic FR market.
CDMO Curia is to collaborate with Corning’s Advanced-Flow Reactor (AFR) team to expand and accelerate continuous flow development and manufacturing for the chemical and biopharmaceutical industries.
